| | | | | | | | | | | | | | | | |
| |
![Collapse](/DXR.axd?r=1_87-p7f1t) | Issue Date FY: 2024 ( Subtotal = $84,580,121 ) (Continued on the next page) |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01CA172145 | Very-long Term Neurocognitive Outcomes in Breast Cancer Survivors (ProbC2) | 001 | 11 | NIH | 4/17/2024 | $16,454 |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01CA172145 | Very-long Term Neurocognitive Outcomes in Breast Cancer Survivors (ProbC2) | 000 | 11 | NIH | 12/13/2023 | $296,157 |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | H79TI086019 | Enhanced Reentry Services for Individuals with Co-occurring Disorders | 000 | 1 | SAMHSA | 7/8/2024 | $383,111 |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R21CA270930 | Modeling Marginal Zone Lymphomagenesis | 000 | 1 | NIH | 7/5/2024 | $399,187 |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R21CA283138 | ATG16L1 isoforms and CRC health disparities | 000 | 1 | NIH | 7/10/2024 | $399,187 |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01AR083443 | Sphingolipid Biosynthesis in the Healthy and Diseased Epidermal Barrier | 000 | 1 | NIH | 6/19/2024 | $706,710 |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R35GM155045 | Dissecting mechanisms of collective migration | 000 | 1 | NIH | 6/20/2024 | $361,054 |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R03AI182614 | Creation and Characterization of Lineage-Restricted Stat5B KO Mice | 000 | 1 | NIH | 6/14/2024 | $67,459 |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01DA060724 | Opioid and non-opioid receptor mechanisms in neurons and glia underlying fentanyl and HIV comorbidity in the striatum | 000 | 1 | NIH | 6/6/2024 | $661,789 |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01AG079944 | UNDERSTANDING OF ESSENTIAL GENE FUNCTION IN AGING | 000 | 1 | NIH | 6/26/2024 | $360,279 |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R24DA061203 | A Virginia Patient Engagement Resource Center to Improve Substance Abuse Treatment Interventions | 000 | 1 | NIH | 6/25/2024 | $443,705 |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | T32CA272382 | Integrative Training Program in Cancer Biology | 000 | 2 | NIH | 6/27/2024 | $363,479 |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01DK137998 | An Integrated Lifestyle Intervention to Promote Cardiometabolic Health among Emerging Adult Women | 000 | 1 | NIH | 3/19/2024 | $310,500 |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01HL163577 | Pediatric POTS: does a periaqueductal gray-vagus nerve interface malfunction explain the natural history with its numerous co-morbidities ? | 000 | 1 | NIH | 7/12/2024 | $775,351 |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01AA031471 | State-dependent modulation of learning | 000 | 1 | NIH | 4/16/2024 | $440,027 |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | F31CA290944 | Elacestrant in breast cancer bone metastases | 002 | 1 | NIH | 5/7/2024 | $0 |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | F31CA290944 | Elacestrant in breast cancer bone metastases | 001 | 1 | NIH | 5/7/2024 | $1,280 |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | F31CA290944 | Elacestrant in breast cancer bone metastases | 000 | 1 | NIH | 4/1/2024 | $42,124 |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | F32AI183749 | Anaplasma phagocytophilum exploitation of regulated exocytosis. | 002 | 1 | NIH | 5/15/2024 | $0 |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | F32AI183749 | Anaplasma phagocytophilum exploitation of regulated exocytosis. | 003 | 1 | NIH | 7/8/2024 | $0 |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | F32AI183749 | Anaplasma phagocytophilum exploitation of regulated exocytosis. | 001 | 1 | NIH | 5/15/2024 | $4,724 |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | F32AI183749 | Anaplasma phagocytophilum exploitation of regulated exocytosis. | 000 | 1 | NIH | 4/9/2024 | $68,684 |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R21DE033842 | Connecting liquid-liquid phase separation with super-enhancers and key oncogene transcription in HNSCC | 000 | 1 | NIH | 2/20/2024 | $228,185 |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01DK139587 | Circular RNAs in Cholestatic Liver Diseases | 000 | 1 | NIH | 3/26/2024 | $561,785 |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | F30MD019536 | Understanding how health determinants shape recovery after critical illness among Virginia Medicaid patients | 000 | 1 | NIH | 5/16/2024 | $43,404 |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | UG1CA287017 | Virginia Cancer Screening Research Network Access Hub (Virginia CSRN Hub) | 000 | 1 | NIH | 2/14/2024 | $864,475 |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R61AI179996 | Development of genetic tools for Orientia tsutsugamushi | 000 | 1 | NIH | 12/18/2023 | $271,688 |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | T32TR004362 | CTSA Predoctoral T32 at Virginia Commonwealth University | 001 | 1 | NIH | 6/5/2024 | $3,765 |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | T32TR004362 | CTSA Predoctoral T32 at Virginia Commonwealth University | 000 | 1 | NIH | 11/30/2023 | $94,781 |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01DA060762 | pTau-related neuron and cognitive dysfunction in opioid-HIV comorbidity: Longitudinal and functional studies | 000 | 1 | NIH | 4/5/2024 | $697,583 |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | K99DA059324 | The influence of astroglial mu opioid receptors in opioid potentiation of HIV neuropathogenesis | 000 | 1 | NIH | 5/29/2024 | $187,151 |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R21EY035974 | DSP nanoparticles for treating nitrogen mustard induced corneal injury | 000 | 1 | NIH | 5/28/2024 | $223,495 |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | E3621728 | LDS - Allopathic Medicine | 000 | 4 | HRSA | 6/27/2024 | $21,761 |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | T2537629 | Addiction Medicine Fellowship | 01 | 5 | HRSA | 7/23/2024 | $24,612 |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | T2537629 | Addiction Medicine Fellowship | 00 | 5 | HRSA | 5/16/2024 | $650,280 |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | U1Q53069 | Geriatrics Workforce Enhancement Program | 00 | 1 | HRSA | 5/23/2024 | $368,914 |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | U1Q53069 | Geriatrics Workforce Enhancement Program | 00 | 1 | HRSA | 5/23/2024 | $631,086 |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | D4033378 | Graduate Psychology Education Programs | 00 | 6 | HRSA | 6/5/2024 | $112,500 |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | D4033378 | Graduate Psychology Education Programs | 00 | 6 | HRSA | 6/5/2024 | $337,500 |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | P1053116 | Rural Health Network Development Planning Grant Program | 00 | 1 | HRSA | 5/22/2024 | $99,327 |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | F30MD018324 | The relationship between social needs and primary care use after enrollment in Virginia’s Medicaid expansion: The influence of sociocultural and built environments | 003 | 2 | NIH | 6/20/2024 | $2,222 |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | F30MD018324 | The relationship between social needs and primary care use after enrollment in Virginia’s Medicaid expansion: The influence of sociocultural and built environments | 002 | 2 | NIH | 11/6/2023 | $40,689 |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01CA285391 | Targeted Degradation of EGFR and HER2 in NSCLC | 000 | 1 | NIH | 7/18/2024 | $503,685 |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01CA285692 | MYCN drives a druggable SUMOylation program in neuroblastoma | 000 | 1 | NIH | 12/27/2023 | $434,312 |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | 90DDUC0148 | Partnership for People with Disabilities: A University Center on Development Disabilities at Virginia Commonwealth University 2023-2028 | 00 | 2 | ACL | 6/26/2024 | $620,675 |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | U01AI169840 | PlzA, cyclic-di-GMP and the enzootic cycle for Lyme disease | 001 | 2 | NIH | 5/14/2024 | $67,458 |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | U01AI169840 | PlzA, cyclic-di-GMP and the enzootic cycle for Lyme disease | 000 | 2 | NIH | 10/23/2023 | $607,136 |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01DA056876 | Long-term microglia-targeted endogenous retrovirus-like particle (ERVLP) delivery of Cas12f editor to cure HIV | 002 | 4 | NIH | 7/3/2024 | $576,854 |
| 2024 | 2024 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01CA244993 | Novel Targeted Combinatorial Therapy for Hepatocellular Carcinoma | 003 | 5 | NIH | 6/27/2024 | $0 |
|